Ventyx Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
51.45
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
6
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.59
|
0.00
|
0.59
|
100.00%
|
|
2022-12-31
|
-0.59
|
0.00
|
0.59
|
100.00%
|
|
2022-09-30
|
-0.44
|
-0.59
|
-0.15
|
-34.09%
|
|
2022-06-30
|
-0.45
|
-0.39
|
0.06
|
13.33%
|
|
2022-03-31
|
-0.52
|
-0.45
|
0.07
|
13.46%
|
|
2021-12-31
|
-1.00
|
-0.36
|
0.64
|
64.00%
|
|
2021-09-30
|
-0.36
|
-3.17
|
-2.81
|
-780.56%
|
|
2021-03-31
|
0.00
|
-0.92
|
-0.92
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.43
|
|
2021-12-31
|
-4.45
|
|
2020-12-31
|
-1.04
|
|
2019-12-31
|
-0.12
|